Viewing Study NCT04550260


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2026-02-25 @ 7:03 PM
Study NCT ID: NCT04550260
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-16
First Post: 2020-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module